Paper3988341
Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.
Adinolfi LE and 3 others. Infect Immun, 1985. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis. Papers, record 3988341. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3988341
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetylmuramyl-Alanyl-Isoglutamine | Major topic |
| Adjuvants, Immunologic | Major topic |
| Antimony | Major topic |
| Antiprotozoal Agents | Major topic |
| Leishmaniasis, Visceral | Major topic |
| Meglumine | Major topic |
| Organometallic Compounds | Major topic |
| Animals | |
| Combined Modality Therapy | |
| Cricetinae | |
| Female | |
| Meglumine Antimoniate | |
| Mesocricetus | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6356272 | The immunobiology of leishmaniasis. | Rev Infect Dis | 1983 | https://conductscience.org/library/papers/6356272 | PubMed |
| 2 | 6638931 | Non-specific and specific stimulation of resistance against Leishmania donovani in C57BL/6 mice. | Ann Clin Lab Sci | 1983 | https://conductscience.org/library/papers/6638931 | PubMed |
| 3 | 6365745 | Stimulation of macrophage protease secretion via liposomal delivery of muramyl dipeptide derivatives to intracellular sites. | Immunology | 1984 | https://conductscience.org/library/papers/6365745 | PubMed |
| 4 | 6231248 | Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: demonstration and characterization of suppressor T cells in noncure mice. | Infect Immun | 1984 | https://conductscience.org/library/papers/6231248 | PubMed |
| 5 | 6543694 | Prophylaxis and treatment of experimental lung metastases in mice after treatment with liposome-encapsulated 6-O-stearoyl-N-acetylmuramyl-L-alpha-aminobutyryl-D-isoglutamine. | Clin Exp Metastasis | 1984 | https://conductscience.org/library/papers/6543694 | PubMed |
| 7 | 4187176 | Problems in leishmaniasis related to immunology. | Curr Top Microbiol Immunol | 1969 | https://conductscience.org/library/papers/4187176 | PubMed |
| 8 | 4606813 | Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. | Biochem Biophys Res Commun | 1974 | https://conductscience.org/library/papers/4606813 | PubMed |
| 9 | 4214869 | Cellular immunity to Leishmania donovani. I. The effect of T cell depletion on resistance to L. donovani in mice. | J Immunol | 1974 | https://conductscience.org/library/papers/4214869 | PubMed |
| 10 | 1065901 | Modulation of the immune response by a synthetic adjuvant and analogs. | Proc Natl Acad Sci U S A | 1976 | https://conductscience.org/library/papers/1065901 | PubMed |
| 11 | 321136 | Target cells for the activity of a synthetic adjuvant: muramyl dipeptide. | Cell Immunol | 1977 | https://conductscience.org/library/papers/321136 | PubMed |
| 12 | 325566 | Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/325566 | PubMed |
| 13 | 873609 | Effect of treatment with BCG on the course of visceral leishmaniasis in BALB/c mice. | Infect Immun | 1977 | https://conductscience.org/library/papers/873609 | PubMed |
| 14 | 563773 | In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-L-alanyl-D-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice. | Cell Immunol | 1978 | https://conductscience.org/library/papers/563773 | PubMed |
| 15 | 313841 | The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity. | Cell Immunol | 1979 | https://conductscience.org/library/papers/313841 | PubMed |
| 16 | 113344 | Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide. | Infect Immun | 1979 | https://conductscience.org/library/papers/113344 | PubMed |
| 17 | 7384789 | Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. | Science | 1980 | https://conductscience.org/library/papers/7384789 | PubMed |
| 18 | 7392013 | Visceral leishmaniasis in mice: protective effect of glucan. | J Reticuloendothel Soc | 1980 | https://conductscience.org/library/papers/7392013 | PubMed |
| 19 | 6967358 | Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor. | Cell Immunol | 1980 | https://conductscience.org/library/papers/6967358 | PubMed |
| 20 | 551094 | Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse. | Int J Immunopharmacol | 1979 | https://conductscience.org/library/papers/551094 | PubMed |
| 21 | 7441647 | Muramyl dipeptide stimulation of particle clearance in several animal species. | J Reticuloendothel Soc | 1980 | https://conductscience.org/library/papers/7441647 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35779182 | The Possible Role of Selected Vitamins and Minerals in the Therapeutic Outcomes of Leishmaniasis. | Biol Trace Elem Res | 2023 | https://conductscience.org/library/papers/35779182 | PubMed |
| 32152715 | Leishmaniasis immunopathology-impact on design and use of vaccines, diagnostics and drugs. | Semin Immunopathol | 2020 | https://conductscience.org/library/papers/32152715 | PubMed |
| 25268355 | Dual immune modulatory effect of vitamin A in human visceral leishmaniasis. | PLoS One | 2014 | https://conductscience.org/library/papers/25268355 | PubMed |
| 18587669 | Imunomodulative effect of liposomized muramyltripeptide phosphatidylethanolamine (L-MTP-PE) on mice with alveolar echinococcosis and treated with albendazole. | Parasitol Res | 2008 | https://conductscience.org/library/papers/18587669 | PubMed |
| 17015627 | Glibenclamide, a blocker of K+(ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasis. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/17015627 | PubMed |
| 10817698 | Activity of the novel immunomodulatory compound tucaresol against experimental visceral leishmaniasis. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10817698 | PubMed |
| 7628580 | Leishmania donovani in hamsters: stimulation of non-specific resistance by novel lipopeptides and their effect in antileishmanial therapy. | Experientia | 1995 | https://conductscience.org/library/papers/7628580 | PubMed |
| 3042625 | Liposomes as drug delivery system in the treatment of infectious diseases. Potential applications and clinical experience. | Infection | 1988 | https://conductscience.org/library/papers/3042625 | PubMed |
| 2387638 | Cyclosporin A treatment converts Leishmania donovani-infected C57BL/10 (curing) mice to a noncuring phenotype. | Infect Immun | 1990 | https://conductscience.org/library/papers/2387638 | PubMed |
| 2360812 | Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a bis(benzyl)polyamine analog. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2360812 | PubMed |
| 2044704 | Leishmania donovani in hamsters: stimulation of non-specific resistance by some novel glycopeptides and impact on therapeutic efficacy. | Experientia | 1991 | https://conductscience.org/library/papers/2044704 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3988341
GET https://conductscience.org/api/papers/v1/3988341/references?page=2